| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 25 Aug 2025 | 30 May 2025 |
| BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2025. BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2025 (As Per NSE Announcement Dated On : 31.07.2025) BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2025 (As Per NSE Announcement Dated On : 25.08.2025) BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2025. (As Per NSE Announcement Dated On : 26.08.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
